Clinical Study of Huaier Granules in Patients With Advanced Breast Cancer Without Visceral Metastasis

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

384

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2027

Conditions
Breast Cancer Stage IV
Interventions
DRUG

Huaier Granule

10g each time, three times a day

Trial Locations (13)

200030

The International Peace Maternity & Child Health Hospital of China welfare institute, Shanghai

200032

Fudan University Shanghai Cancer Center, Shanghai

200092

Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai

225001

Northern Jiangsu People's Hospital, Yangzhou

226006

Nantong First People's Hospital, Nantong

310005

Zhejiang Cancer Hospital, Hangzhou

314000

The First Hospital of Jiaxin, Jiaxin

318001

Taizhou Central Hospital, Taizhou

323020

Lishui Municipal Central Hospital, Lishui

410011

The First Hospital of Hunan University of Chinese Medicine, Changsha

410013

The Third Xiangya Hospital of Central South University, Changsha

450052

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

050011

The Fourth Hospital of Hebei Medical University, Shijiazhuang

All Listed Sponsors
collaborator

LinkDoc Technology (Beijing) Co. Ltd.

INDUSTRY

collaborator

Huazhong University of Science and Technology

OTHER

lead

Fudan University

OTHER